Main Menu

Our industrial collaborators

The Institute of Cancer Research collaborates with industrial partners over a range of projects – from drug discovery programmes and biomarker studies, to the development of high intensity focussed ultrasound for the treatment of cancer.

A box of pills for use in a clinical trial

Some of our recent collaborations have included:

Astex – a 3.5-year drug discovery collaboration aims to identify a preclinical candidate which inhibits the molecule MMSET.

AstraZeneca – a range of programmes and projects under a strategic alliance

BACIT – co-investment alongside Sareum and the CRT Pioneer Fund in the Chk1 drug development programme

CRT Pioneer Fund – a collaboration and licence agreement for the MPS-1 drug discovery programme

Domainex – providing chemistry support on a 5-year drug discovery collaboration funded by the Wellcome Trust

Elekta – a range of projects in the field of radiotherapy and imaging

Enzon pharmaceuticals – a biomarker collaboration

Tumour Profiling Unit (Jan Chlebik for the ICR, 2013)

Horizon – collaboration to identify synthetic lethal cancer targets using Horizon’s isogenic cell lines

Illumina, Inc. – collaborative development of a cancer susceptibility genetic screening panel – TruSight Cancer

Janssen – a 2.5-year drug discovery collaboration

Merck Serono – continuation of a 4-year collaboration for a further 2 years on development of inhibitors of the Wnt pathway

Nuevolution – a drug discovery collaboration working on difficult to drug targets

Onyx – a clinical trial of a novel α-folate receptor-mediated thymidylate synthase inhibitor using a study drug that was developed at ICR

Phillips – A collaboration in the field of High Intensity Focused Ultrasound (HIFU) treatment aiming to evaluate and optimise novel applications of HIFU in the treatment of cancer

Ventana – a multi-program collaboration providing equipment and support for a number of projects

Other industrial collaborators include: Amgen, EMD Millipore, Genentech, GSK, Morphosys, Oncolytics, PreCOS, Roche, Sanofi Aventis, Symphogen and Teva.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.